Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Charles River Laboratories VP Christopher Perkins On Building Preclinical Facilities In China: An Interview With PharmAsia News (Part 2 of 2)

This article was originally published in PharmAsia News

Executive Summary

Wilmington, Mass.-based contract research organization Charles River Laboratories offers drug discovery and development services to global pharmaceutical and biotechnology companies, government agencies, and leading academic institutions. Senior VP Christopher Perkins recently spoke with PharmAsia News about the company's operations in China and the landscape there for preclinical services.

You may also be interested in...



Yangtze Delta Expected To Be Largest CRO Cluster By 2015

SUZHOU, China - China's Yangtze delta, which includes Shanghai, Suzhou, Nanjing and Hangzhou, will be the largest CRO cluster in the world by 2015 and Shanghai will be the number one city in the world by number of scientists engaged in commercial drug discovery, Kewen Jin, GM of Charles River China, said during the BioBay Investor Forum in Suzhou Aug. 28

Yangtze Delta Expected To Be Largest CRO Cluster By 2015

SUZHOU, China - China's Yangtze delta, which includes Shanghai, Suzhou, Nanjing and Hangzhou, will be the largest CRO cluster in the world by 2015 and Shanghai will be the number one city in the world by number of scientists engaged in commercial drug discovery, Kewen Jin, GM of Charles River China, said during the BioBay Investor Forum in Suzhou Aug. 28

Charles River Laboratories VP Christopher Perkins On Building Preclinical Facilities In China: An Interview With PharmAsia News (Part 1 of 2)

Wilmington, Mass.-based contract research organization Charles River Laboratories offers drug discovery and development services to global pharmaceutical and biotechnology companies, government agencies, and leading academic institutions. Senior VP Christopher Perkins recently spoke with PharmAsia News about the company's operations in China and the landscape there for preclinical services.

Related Content

UsernamePublicRestriction

Register

ID1122434

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel